Two independent teams described potential roles for gut microbes, and the compounds they produce, in schizophrenia, depression, and mental quality of life.
The parties will test and implement BioLegend's TotalSeq antibodies as part of a workflow combing single-cell proteomics with single-cell transcriptomics.
Researchers from Belgium analyzed the transcriptomes of almost 100,000 single cells from lung cancer patients, most of them stromal cells.
Gut microbiome researchers have identified features associated with everything from Crohn's disease to salt intake, immune activity, and hypertension.
Researchers sequenced and analyzed the genome of Apostasia shenzhenica, which is part of a small sister lineage to other plants in the Orchidaceae family, uncovering new evolutionary clues.
The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.
The blood-based test will use a 23-gene expression signature identified by researchers at VIB-KU Leuven and their collaborators.
The institutes will exchange investigators, form research collaborations in various areas of plant biotechnology, and start new companies together.
With the help of TCGA sequence data, researchers uncovered expression of a long, non-coding RNA called SAMMSON that appears to be specific to melanoma.
The new R9 pore, which the company has licensed from VIB in Belgium and plans to release for the MinIon and the PromethIon, is based on the E. coli CsgG nanopore.
Thermo Fisher Scientific says it will no longer sell DNA sequencing machines in China's Xinjiang region, according to the Wall Street Journal.
University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.
New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.
In Nature this week: protein-coding variants associated with body-fat distribution, and more.